# EDGAR Filing Document

**Accession Number:** 0000314227
**File Stem:** 0001654954-25-009630
**Filing Date:** 2025-8
**Character Count:** 22886
**Document Hash:** 5ab1c1433535fe4989a6a25d1aa9b06b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-009630.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001654954-25-009630

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250814

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TOMI Environmental Solutions, Inc.
- **CENTRAL INDEX KEY:** 0000314227
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL ORGANIC CHEMICALS [2860]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 591947988
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39574
- **FILM NUMBER:** 251217920

**BUSINESS ADDRESS:**
- **STREET 1:** 8430 SPIRES WAY
- **CITY:** FREDERICK
- **STATE:** MD
- **ZIP:** 21701
- **BUSINESS PHONE:** 8005251698

**MAIL ADDRESS:**
- **STREET 1:** 8430 SPIRES WAY
- **CITY:** FREDERICK
- **STATE:** MD
- **ZIP:** 21701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ozone Man, Inc.
- **DATE OF NAME CHANGE:** 20071130

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** RPS GROUP INC
- **DATE OF NAME CHANGE:** 19940818

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAUPHIN INC
- **DATE OF NAME CHANGE:** 19940818

?xml version='1.0' encoding='ASCII'? tomz_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **August 14, 2025**

---

| |
|:---|
| **TOMI ENVIRONMENTAL SOLUTIONS, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Florida** | **000-09908** | **59-1947988** |
| (State or other jurisdiction <br>of incorporation) | (Commission <br>File Number) | (I.R.S. Employer <br>Identification No.) |

---

---

| |
|:---|
| **8430 Spires Way**<br>**<u>Frederick, Maryland 21701</u>** |
| (Address of principal executive offices) (Zip Code) |

---

---

| |
|:---|
| **<u>(800) 525-1698</u>** |
| (Registrant's telephone number, including area code) |

---

---

| |
|:---|
| **<u>Not Applicable</u>** |
| (Former name or former address, if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.01 par value per share | TOMZ | Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02 Results of Operations and Financial Condition.**

On August 14, 2025, TOMI Environmental Solutions, Inc. issued a press release regarding its financial results for the second quarter ended June 30, 2025. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1. No additional information is included in this Current Report on Form 8-K.

The information included in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed "filed" for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

See the Exhibit Index below, which is incorporated by reference herein.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [99.1](tomz_ex991.htm) | [Press Release date August 14, 2025](tomz_ex991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **TOMI ENVIRONMENTAL SOLUTIONS, INC.** | **TOMI ENVIRONMENTAL SOLUTIONS, INC.** |
| Date: August 14, 2025 | By: | /s/ Halden S. Shane |
|  |  | Name: Halden S. Shane |
|  |  | Title: Chief Executive Officer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**FOR IMMEDIATE RELEASE**

**TOMI Environmental Solutions, Inc. Reports Q2 2025 Financial Results and Outlines Growth Initiatives.**

**Frederick, MD – August 14, 2025** – TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the quarter ended June 30, 2025, and provided an update on strategic initiatives designed to drive long-term growth.

**Q2 2025 Highlights:**

· **Service & Training Growth:** Service and training revenue increased year-over-year in both the quarter (33%) and first half of 2025 (46%), reflecting growing demand for high-value decontamination services.

· **Strong Gross Margins:** Gross profit margin remained healthy at **66%** in Q2, underscoring the efficiency of operations and the value of the Company's technology.

· **Operational Efficiencies:** Reduced selling, research, and administrative expenses year-to-date, demonstrating disciplined cost management.

· **International Reach:** Continued penetration into global markets, with nearly 20% of Q2 revenue generated internationally.

· **Product Innovation:** Ongoing investment in R&D to expand applications of SteraMist® across life sciences, healthcare, food safety, and commercial markets.

**Financial Results for the three and six months ended June 30, 2025, compared to June 30, 2024**

· Sales, net was $1,031,000 compared to $3,013,000 for the three months ended June 30, 2025 and 2024, respectively. Sales, net was $2,608,000 compared to $4,127,000 for the six months ended June 30, 2025 and 2024, respectively. This was primarily driven by customers deferring capital expenditure projects due to the uncertain economic environment with the impact of announced and implemented tariffs on their supply chains, and long-term planning. This was not a factor in the second quarter of 2024, which had higher sales in mobile equipment of approximately $1.0 million and our Custom Engineered Systems or CES of approximately $0.5 million.

· SteraMist solution sales up 40% year over year for the six months ended June 30, 2025.

· Service-based revenue for the three months ended June 30, 2025, and 2024, was $378,000 and $285,000, respectively, representing a year over year increase of $93,000, or 33%. Service-based revenue for the six months ended June 30, 2025, and 2024, was $955,000 and $656,000, respectively, representing a year over year increase of $299,000, or 46%.

· Gross margin was 66% compared to 62% in the same prior quarter. The improved gross profit margins were attributable to our product mix in sales including higher sales of BIT solution and service offerings for the three months ended June 30, 2025, compared to the same period last year.

· Operating loss was $(1,133,000), compared to income from operations of $122,000 for the three months ended June 30, 2025, and 2024, respectively. Operating loss was $(1,887,000), compared to $(1,105,000) for the six months ended June 30, 2025, and 2024, respectively.

· Net loss was $(1,238,000) or $(0.06) per basic and diluted share, compared to net income of $30,000 or $0.00 per basic and diluted share for the three months ended June 30, 2025, and 2024, respectively. Net loss was $(1,493,000) or $(0.07) per basic and diluted share, compared to $(1,280,000) or $(0.06) per basic and diluted share for the six months ended June 30, 2025, and 2024, respectively.

**Recent Business Highlights:** 

· Our sales order backlog as of June 30, 2025, totaled approximately $1.4 million.

· As of August 7, 2025, the combined total of recognized revenue, deferred revenue, and sales order backlog was approximately $4.6 million, with active projects on schedule for delivery in 2025. In addition, we are negotiating approximately $2 million in new custom and integrated contracts, with bids expected to close prior to year-end.

· As of the date of this report, our open opportunities for our three product offerings for Custom Engineered System (CES), Hybrid Solutions and SteraMist (SIS) total approximately $15 million, of which $7 million are designated as high priority. High-priority opportunities are those with which we are actively engaged through ongoing discussions on specifications, submitted formal proposals, or pursuits via established contractor relationships.

· On June 12, 2025, the Company was honored with the prestigious 2025 "Disinfection and Decontamination Products Company of the Year" award by MedTech Outlook. This recognition highlights TOMI's unwavering commitment to excellence and the strong confidence customers and industry peers have in its SteraMist iHP technology.

· On June 16, 2025, the Company announced the advancement of our new product line, the SteraMist Integration System with the Standalone or SIS-SA making its debut as the first system installed with a leading contract development and manufacturing organization.

**Leadership Update**

In May 2025, the Company appointed David Vanston as Chief Financial Officer, bringing extensive financial and operational experience to the leadership team to support growth and the capital strategy.

**Liquidity & Capital Access**

As of June 30, 2025, the Company had working capital of $2.8 million; furthermore, cash used in operations improved by over $1 million as compared to the prior year quarter which was primarily attributable to management action on working capital with a focus on accounts receivable and inventory.

The Company successfully completed a $435,000 convertible note financing in the first half of 2025 to provide additional working capital and support growth initiatives.

**CEO Commentary**

"While Q2 reflected a softer product sales cycle, we remain confident in our growth strategy and optimistic about our future opportunities. As part of executing on this strategy, we plan to expand our team before year-end, adding talent in the C-suite, sales, customer support and IHP service technicians. We are particularly encouraged by the sustained growth in our service and training division, the resilience of our margins, and the progress in broadening our customer base," said Dr. Halden Shane, Chief Executive Officer and Chairman of the Board of TOMI. "Our technology continues to be recognized for its effectiveness and environmental sustainability, and we remain focused on leveraging this strength to capture opportunities in both domestic and international markets. I encourage investors to read our MD&A in our recent second quarter Q filings."

**Looking Ahead**

The Company is executing a focused strategy to:

· Expand recurring service contracts with key customers and explore new product lines and/or service offerings to generate a steady income stream

· Drive year on year recurring revenue growth by increasing SteraMist solution sales

· Continue to grow our presence internationally utilizing targeted marketing campaigns and referral business.

· Pursue additional government and institutional partnerships

· Strengthen balance sheet flexibility through disciplined financial management

· Strengthen corporate team to support growth

**Conference Call Information**

TOMI will hold a conference call to discuss Second Quarter 2025 results at 4:30 p.m. ET today, August 14, 2025.

To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time and provide participant access code 838858, or request the "TOMI Environmental Solutions second quarter earnings call." International callers please dial (973) 528-0011. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link: https://www.webcaster4.com/Webcast/Page/2262/52861.

A replay of the teleconference will be available until Thursday, August 28, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code: 52861. A replay of the webcast will be available for at least 90 days on the company's website, starting approximately one hour after the completion of the call.

**TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®**

TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

**Forward-Looking Statements**

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, our strategies to grow revenue and expand business development, our expectation with respect to the remainder of 2025, including schedule of delivery, realization of revenue from backlog and open opportunities; our ability to generate lead and referral for sales, the expectation to capture new markets, our ability to improve financial performance and the statements under the section entitled "Looking Ahead". Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

The following represents our consolidated balance sheets and statement of operations from our recently filed Form 10-Q:

**TOMI ENVIRONMENTAL SOLUTIONS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| **ASSETS** | | |
|  | **June 30, 2025** | **December 31,**  |
| Current Assets: | **(Unaudited)** | **2024** |
| Cash and Cash Equivalents | $569450 | $664879 |
| Accounts Receivable – net | 1054071 | 1881138 |
| Inventories - net | 3267460 | 3578202 |
| Vendor Deposits | 257509 | 35895 |
| Prepaid Expenses | 254261 | 332999 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Current Assets | 5402751 | 6493113 |
| Property and Equipment – net | 749148 | 875449 |
| Other Assets: |  |  |
| Intangible Assets – net | 1301021 | 1250574 |
| Operating Lease - Right of Use Asset | 361790 | 399254 |
| Other Assets | 661240 | 675348 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Other Assets | 2324051 | 2325176 |
| Total Assets | $8475950 | $9693738 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY**  |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts Payable | $1001121 | $1924379 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accrued Expenses and Other Current Liabilities | 736480 | 455675 |
| &nbsp;&nbsp;&nbsp;&nbsp; Deferred Revenue | 719235 | 211724 |
| &nbsp;&nbsp;&nbsp;&nbsp; Current Portion of Long-Term Operating Lease | 136227 | 129132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Current Liabilities | 2593063 | 2720910 |
| Long-Term Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Long-Term Operating Lease, Net of Current Portion | 444327 | 513395 |
| &nbsp;&nbsp;&nbsp;&nbsp; Convertible Notes Payable, net discount of $253,270 and $239,506 at June 30, 2025 and December 31, 2024, respectively | 2781730 | 2360494 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Long-Term Liabilities | 3226057 | 2873889 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Liabilities | 5819120 | 5594799 |
| Commitments and Contingencies |  |  |
| Shareholders' Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cumulative Convertible Series A Preferred Stock; par value $0.01 per share, 1,000,000 shares authorized; 63,750 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively | 638 | 638 |
| &nbsp;&nbsp;&nbsp;&nbsp; Cumulative Convertible Series B Preferred Stock; $1,000 stated value; 7.5% Cumulative dividend; 4,000 shares authorized; none issued and outstanding at June 30, 2025, and December 31, 2024, respectively |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Common stock: par value $0.01 per share, 250,000,000 shares authorized; 20,075,205 and 20,015,205 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 200752 | 200152 |
| &nbsp;&nbsp;&nbsp;&nbsp; Additional Paid-In Capital | 58251540 | 58201140 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accumulated Deficit | (55796100) | (54302991) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Shareholders' Equity | 2656830 | 4098939 |
| Total Liabilities and Shareholders' Equity | $8475950 | $9693738 |

---

**TOMI ENVIRONMENTAL SOLUTIONS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** | **For the six months ended** | **For the six months ended** |
|  | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Sales, net  | $1031115 | $3013392 | $2607673 | $4127479 |
| Cost of Sales | 353991 | 1158876 | 978804 | 1602295 |
| Gross Profit | 677124 | 1854516 | 1628869 | 2525184 |
| Operating Expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Professional Fees | 183874 | 84327 | 403190 | 282326 |
| &nbsp;&nbsp;&nbsp;&nbsp; Depreciation and Amortization | 69238 | 76554 | 137780 | 154475 |
| &nbsp;&nbsp;&nbsp;&nbsp; Selling Expenses | 240462 | 366265 | 486868 | 655334 |
| &nbsp;&nbsp;&nbsp;&nbsp; Research and Development | 84106 | 61614 | 128686 | 129585 |
| &nbsp;&nbsp;&nbsp;&nbsp; Consulting Fees | 63098 | 23095 | 165864 | 136730 |
| &nbsp;&nbsp;&nbsp;&nbsp; General and Administrative | 1169035 | 1120849 | 2193635 | 2271398 |
| Total Operating Expenses | 1809813 | 1732704 | 3516023 | 3629848 |
| Income (loss) from Operations | $(1132689) | $121812 | $(1887154) | $(1104664) |
| Other Income (Expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Other Income |  |  | 534912 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Interest Income | 1421 | 1845 | 84311 | 11751 |
| &nbsp;&nbsp;&nbsp;&nbsp; Interest Expense | (106248) | (93459) | (225178) | (187079) |
| Total Other Income (Expense) | (104827) | (91614) | 394045 | (175328) |
| Income (loss) before income taxes | (1237516) | 30198 | (1493109) | (1279992) |
| Provision for Income Taxes | - | - | - | - |
| Net Income (loss) | $(1237516) | $30198 | $(1493109) | $(1279992) |
| Net income (loss) Per Common Share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | $(0.06) | $0.00 | $(0.07) | $(0.06) |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted | $(0.06) | $0.00 | $(0.07) | $(0.06) |
| Basic Weighted Average Common Shares Outstanding | 20047512 | 19984875 | 20031447 | 19968495 |
| Diluted Weighted Average Common Shares Outstanding | 20047512 | 22133562 | 20031447 | 19968495 |

---